C07D 209/88
With hetero atoms or with carbon atoms having three bonds to hetero
Official title: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
C07D209/88 (With hetero atoms or with carbon atoms having three bonds to hetero) appears on 778 US grants and 953 published applications in this corpus.
Search patents in C07D- Granted patents
- 778
- Published applications
- 953
- Assignees
- 418
- Inventors
- 2,449
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 14 | 0 |
| 1977 | 8 | 0 |
| 1978 | 3 | 0 |
| 1979 | 6 | 0 |
| 1980 | 4 | 0 |
| 1981 | 8 | 0 |
| 1982 | 7 | 0 |
| 1983 | 3 | 0 |
| 1984 | 3 | 0 |
| 1985 | 2 | 0 |
| 1986 | 2 | 0 |
| 1987 | 4 | 0 |
| 1988 | 5 | 0 |
| 1989 | 5 | 0 |
| 1990 | 8 | 0 |
| 1991 | 11 | 0 |
| 1992 | 3 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 3 | 0 |
| 1996 | 2 | 0 |
| 1997 | 10 | 0 |
| 1998 | 14 | 0 |
| 1999 | 13 | 0 |
| 2000 | 6 | 0 |
| 2001 | 10 | 3 |
| 2002 | 17 | 18 |
| 2003 | 5 | 25 |
| 2004 | 16 | 33 |
| 2005 | 9 | 29 |
| 2006 | 13 | 33 |
| 2007 | 15 | 38 |
| 2008 | 16 | 50 |
| 2009 | 21 | 36 |
| 2010 | 23 | 33 |
| 2011 | 34 | 36 |
| 2012 | 28 | 32 |
| 2013 | 30 | 33 |
| 2014 | 26 | 31 |
| 2015 | 27 | 39 |
| 2016 | 33 | 49 |
| 2017 | 33 | 52 |
| 2018 | 34 | 45 |
| 2019 | 44 | 59 |
| 2020 | 31 | 53 |
| 2021 | 33 | 36 |
| 2022 | 27 | 40 |
| 2023 | 37 | 40 |
| 2024 | 30 | 40 |
| 2025 | 27 | 50 |
| 2026 | 11 | 20 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Heterocyclic compound and organic light emitting device comprising same1 Sep 2026US 12,727,378 B2Lt Materials Co., Ltd.
- Small molecule BAX inhibitors and uses thereof18 Aug 2026US 12,708,621 B2Albert Einstein College of Medicine
- Nitrogen-branched non-linear pegylated lipid containing a tertiary amine and application thereof18 Aug 2026US 12,708,675 B2Xiamen Sinopeg Biotech Co., Ltd.
- p53 modulators and uses thereof28 Jul 2026US 12,692,273 B2The Regents of the University of California
- Organic electroluminescence device and amine compound for organic electroluminescence device28 Jul 2026US 12,692,433 B2Samsung Display Co., Ltd.
- Compound for organic optoelectronic device, composition for organic optoelectronic device, organic optoelectronic device, and display device8 Oct 2026US 2026/0314259 A1Samsung SDI.Co., Ltd.
- Heterocyclic compound and organic light-emitting device comprising same1 Oct 2026US 2026/0305166 A1Lt Materials Co., Ltd.
- Benzocarbazole derivatives as inhibitors of drp110 Sep 2026US 2026/0265212 A1Asha Therapeutics LLC
- Organic compound, electronic element and electronic apparatus using the same20 Aug 2026US 2026/0247792 A1Shaanxi Lighte Optoelectronics Material Co., Ltd.
- Light-emitting device including heterocyclic compound, electronic apparatus and electronic equipment each including the light-emitting device, and the heterocyclic compound13 Aug 2026US 2026/0239814 A1Samsung Display Co., Ltd.
Most cited
By later US patents
- Carvedilol187US 7,056,942 B2Teva Pharmaceutical Industries Ltd. · 2006
- Electrophotographic element with carbazole hydrazone or anile charge transport compounds130US 4,297,426 ARicoh Company, Ltd. · 1981
- (Hydroxyphenyl)-1H-indole-3-carbaldehyde oxime derivatives as estrogenic agents91US 7,250,440 B2Wyeth · 2007
- Carbazolyl-(4)-oxypropanolamine compounds and therapeutic compositions82US 4,503,067 ABoehringer Mannheim GmbH · 1985
- Npyy5 antagonists74US 6,699,891 B1Shionogi & Co., Ltd. · 2004